By Lynn McCain 

Congratulations on the investiture of Annette Kim, M.D., Ph.D., Professor of Pathology, and Director of the Division of Diagnostic Genetics and Genomics, with the Henry Clay Bryant Professorship in Pathology. This professorship was established to honor the legacy of Dr. Bryant, who received his medical degree and completed his pathology residency at the University of Michigan. Dr. Bryant went on to lead an external pathology laboratory while also serving as a lecturer in pathology at Michigan throughout his career. This professorship was established in 2011 by his estate in partnership with the Department of Pathology.

Dr. Kim was joined by her husband Michael Wood, sons Samuel and Benjamin Wood, sister Dorothy Corbett, and guests, Dr. Robert Wilson, Professor of Pathology and Laboratory Medicine at Children’s Hospital of Philadelphia, and Dr. Joel Moncur, Associate Professor of Pathology at the Uniformed Services University of Health Science.  

“In addition to her brilliance and her accomplishments, Annette upholds the highest standards for ethics and professionalism in academic medicine,” praised Dr. Wilson. “Annette does what she does, first and foremost, for the benefit of patients. I can think of no higher compliment than this, and I can think of no one more deserving of this honor than Annette.”

Dr. Moncur added, “Promotion isn't solely about past achievements; it's about recognizing the potential for future impact.  Dr. Annette Kim's potential extends beyond her impressive track record.  She has unlimited potential to serve patients, to elevate the university, and to advance the practice of medicine.”
 

"I am tremendously honored to receive the Henry Clay Bryant professorship," responded Kim. "Just as it takes a village to raise a child, an endowed professorship is the time to be grateful to all the beloved mentors and colleagues throughout my career. At the same time, the professorship provides me the means to pay that mentorship forward by supporting the pathologists of the future and my entire division in our collective educational and academic missions, all of which derives from state-of-the-art diagnostic genetic and genomic testing. I am excited to see what we can all accomplish together!"
 

Dr. Kim is an international leader in the field of molecular pathology and is a role model for diagnostic expertise, scholarly productivity, dedicated teaching, and noteworthy research. She has published more than 100 peer-reviewed articles, thirteen book chapters, and more than 180 abstracts/posters. She is a widely sought-after lecturer and has an extensive teaching portfolio. She has received many honors including five teaching awards; the 1998 Damon Runyon-Walter-Winchell Fellow Award; the 2007 William Pepper Fellowship Award; the 2008 Paul E. Strandjord Young Investigator Award, Academy of Clinical Laboratory Physicians and Scientists;  the 2011 Clinician Scientist Development Award, Doris Duke Charitable Foundation; the 2018 James D. Griffin, MD, Medical Oncology Team Science Award, Dana Farber Cancer Institute; the 2019 Public Service Award, College of American Pathologists; and the 2020 Partners in Excellence Award Optimizing Collaboration, Partners Healthcare System.

Dr. Kim received her M.D. and Ph.D. from Harvard Medical School in 1998. She completed her combined residency training in clinical pathology as well as her fellowship training in hematopathology at the University of Pennsylvania in 2008. Upon completion of her training, she joined Cooper University Hospital as Medical Director for one year prior to joining the faculty at Vanderbilt University Medical Center in 2009, and in 2015 joined the faculty at Brigham and Women’s Hospital where she served as director of the Translation Biomarker Core and Heme-Molecular Lab, both in the Center of Advanced Molecular Diagnostics, co-director of the Interpretive Genomics Program at the Dana Farber Cancer Institute, director of the BH3 Profiling Laboratory, and the PI of the molecular core for the Leukemia SPORE Program. Dr. Kim joined our faculty on July 1, 2023.